Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Philippe Truffinet

1PUBLICATIONS

9CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 09, 2024

Phase 1 Trials of Gatralimab, a Next-Generation Humanized Anti-CD52 Monoclonal Antibody, in Participants with Progressive Multiple Sclerosis.

Fredrik N Albach, Christian Geier, Christian Keicher

Pageof 1

Frequent Collaborators

1 joint publications

Fredrik N Albach

1 joint publications

Christian Geier

1 joint publications

Christian Keicher

1 joint publications

Maximilian G Posch

1 joint publications

Stephan J Schreiber

1 joint publications

Gerald Grütz

1 joint publications

Levent Akyüz

1 joint publications

Xiaodong Luo

1 joint publications

Annaig Le-Halpere

Frequent Collaborators

1 joint publications

Fredrik N Albach

1 joint publications

Christian Geier

1 joint publications

Christian Keicher

1 joint publications

Maximilian G Posch

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

See more related videos

Top Related Videos

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on : Mar 28, 2021

See more related videos